SCHEMBL316932

SCHEMBL316932

CCCCCCC(CCCCCC)(C(=O)O)C(O)(C(=O)O)C(CCCCCC)(C(=O)O)C(=O)CCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.35
PPARG P37231 7/20 0.35
PPARD Q03181 7/20 0.35
PPARA Q07869 7/20 0.35
HDAC11 Q96DB2 5/20 0.35
TSHR P16473 4/20 0.35
PTPN1 P18031 3/20 0.35
ALDH1A1 P00352 2/20 0.35
TLR2 O60603 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
FABP4 P15090 2/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
MEN1 O00255 1/20 0.35
ESR1 P03372 1/20 0.35
ALOX15 P16050 1/20 0.35
PDE4A P27815 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE3A Q14432 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9955173 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9955236 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9955999 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9954638 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9956321 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9955777 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9955140 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9954924 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9954825 1.00 GPR84 (0.35) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL16341863 0.94 FAAH (0.31) MEN1KMT2AHSD17B10FAAHCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS ICU MEDICAL INC (US) 2026-05-21 US claimed
EP-3990037-B1 LAYERED COLLAGEN DRESSING WITH EXTENDED BACTERIA AND BIOFILM REDUCING CAPABILITIES SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-06-19 EP claimed
EP-3713979-B1 MEDICAL DEVICES SOLVAY SPECIALTY POLYMERS IT (IT) 2024-03-06 EP claimed
US-20230399618-A1 METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2023-12-14 US claimed
WO-2023229962-A1 PROCESS FOR REMOVING WATER FROM A FUNCTIONAL INGREDIENT COMPOSITION, AND COMPOSITIONS CONTAINING THE RESULTING PRODUCT CHEMLINK LABORATORIES, LLC (US) 2023-11-30 WO claimed
US-20230180741-A1 DEHP-Free Blood Storage and Methods of Use Thereof HEMANEXT INC. (US) 2023-06-15 US claimed
US-11672890-B2 Medical devices SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) 2023-06-13 US claimed
WO-2023086494-A1 METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2023-05-19 WO claimed
EP-4149257-A2 DEHP-FREE BLOOD STORAGE AND METHODS OF USE THEREOF Hemanext Inc. (US) 2023-03-22 EP claimed
WO-2021231650-A2 DEHP-FREE BLOOD STORAGE AND METHODS OF USE THEREOF HEMANEXT INC. (US) 2021-11-18 WO claimed
EP-1299048-A4 BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES SHUKLA ATUL J (US) 2005-09-28 EP claimed
EP-0996667-B1 PLASTIC COMPOSITIONS INCLUDING VITAMIN E FOR MEDICAL CONTAINERS AND METHODS FOR PROVIDING SUCH COMPOSITIONS AND CONTAINERS BAXTER INT (US) 2004-08-25 EP claimed
JP-2004511431-A 2004-04-15 JP claimed
US-20040018238-A1 Biodegradable vehicles and delivery systems of biolgically active substances SHUKLA ATUL J (US) 2004-01-29 US claimed
EP-1299048-A1 BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES Shukla, Atul J. (US) 2003-04-09 EP claimed
EP-0996677-B1 PLASTIC COMPOSITIONS FOR MEDICAL CONTAINERS AND METHODS FOR PROVIDING SUCH CONTAINERS AND FOR STORING RED BLOOD CELLS BAXTER INT (US) 2002-11-20 EP claimed
US-6432438-B1 BLENDING CO- OR HOMOPOLYMERS, PLASTICIZERS AND DRUGS TO FORM A DRUG DELIVERY SYSTEM, HAVING DOSAGE FLEXIBILITY AND STABILITY; TIME-RELEASE AGENTS SHUKLA ATUL J (US) 2002-08-13 US claimed
WO-2002000137-A1 BIODEGRADABLE VEHICLES AND DELIVERY SYSTEMS OF BIOLOGICALLY ACTIVE SUBSTANCES SHUKLA ATUL J (US) 2002-01-03 WO claimed
EP-0516818-B1 IMPROVED MATERIAL FOR MEDICAL GRADE TUBING BAXTER INT (US) 1998-08-12 EP claimed
EP-0138147-B1 CITRATE-ESTER PLASTICIZED PVC BLOOD CONTAINERS Bayer Corporation (US) 1993-04-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS TFEB, LAGE3, RICTOR GPR84 2468/4885PPARG 2021/4885PPARD 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.